Skip to main content

JHS · JHS Svendgaard Laboratories Limited · Financials

8.09 INR -0.09 (-1.10%) At close · Nov 13
Volume · Nov 13 1693 Avg daily vol (14 sessions) 4054

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
1.02B +10.5%
FY2026 Revenue FY2018–FY2026
Net Income
-19.22M +90.3%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
-26.58M +48.7%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2018
INR 1.08B 1.02B 919.97M 707.98M 962.07M 862.52M 1.01B 1.39B 1.43B
INR 74.03M 74.96M 79.5M 63.46M 74.65M 70.52M 72.55M 87.61M 68.13M
INR 11.09M 8.59M 5.65M 4.6M 10.42M 13.94M 12.4M 19.53M 7.38M
INR -32.41M -22.91M -125.08M -34.29M -218.4M 1.03M 9.68M -58.43M 384.24M
INR -20.58M -3.68M 71.88M 6.29M -50.65M 43.92M 9.4M -7.24M 123.69M
INR -11.83M -19.22M -197.44M -40.58M -154.64M -40.52M 11.98M -19.79M 261.49M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.